Sort
15,842 grants matching “pancreatic cancer”
Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer
$440,874Pankaj Kumar Singh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2022 · CA
Targeted Glycomics and Affinity Reagents for Cancer Biomarker Development
$440,750Brian B Haab · Van Andel Research Institute · U01 · FY2016 · CA
Systematic characterization of cancer variants using single-cell functional genomics
$440,728Thomas Maxwell Norman · Sloan-Kettering Inst Can Research · R33 · FY2022 · CA
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
$440,712Karen M Mann · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Project 2: Clinical Development of the Pancreatic Cancer Drug Conjugate SW v-49
$440,697William G Hawkins · Washington University · P50 · FY2019 · CA
Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response
$440,640Bassel El-Rayes · University Of Alabama At Birmingham · UH3 · FY2023 · CA
Epigenetic Drivers of Cancer Progression
$440,626Andrew P Feinberg · Johns Hopkins University · R01 · FY2016 · CA
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$440,580Rongfu Wang · Methodist Hospital Research Institute · U54 · FY2019 · CA
Defining the roles of RIPK1 and RIPK3 in emergency hematopoiesis
$440,417Ben Adam Croker · Boston Children'S Hospital · R01 · FY2015 · HL
Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer
$440,314Xiao-Ou Shu · Vanderbilt University Medical Center · R01 · FY2023 · CA
Rational Oncolytic Virotherapy For Pancreatic Cancer Using Vesicular Stomatitis Virus
$440,220Valery Zurabovich Grdzelishvili · University Of North Carolina Charlotte · R15 · FY2019 · CA
Project 2: Contribution of the Stromal Microenvironment to Early Dissemination
$440,215Mayumi Ito · New York University School Of Medicine · U54 · FY2023 · CA
Mechanisms regulating neurotensin secretion and function
$440,213Bernard Mark Evers · University Of Kentucky · R01 · FY2021 · DK
Mechanisms regulating neurotensin secretion and function
$440,213Bernard Mark Evers · University Of Kentucky · R01 · FY2019 · DK
Mechanisms regulating neurotensin secretion and function
$440,213Bernard Mark Evers · University Of Kentucky · R01 · FY2020 · DK
Mechanisms regulating neurotensin secretion and function
$440,213Bernard Mark Evers · University Of Kentucky · R01 · FY2018 · DK
Mechanisms regulating neurotensin secretion and function
$440,213Bernard Mark Evers · University Of Kentucky · R01 · FY2017 · DK
MULTIPLEX CHEMICAL TAGS FOR HIGH-THROUGHPUT GLYCAN AND GLYCOPEPTIDE QUANTITATION AND CHARACTERIZATION
$440,182Lingjun Li · University Of Wisconsin-Madison · U01 · FY2019 · CA
P-4: Direct Delivery of Immune-modulating Therapies to the Pancreatic Tumor Site
$440,146Pinku Mukherjee · Mayo Clinic Rochester · P50 · FY2009 · CA
Mechanism-Based Use of Chk1 Inhibitors in Pancreas Cancer
$440,121Jonathan Maybaum · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
Serum-based assays for pancreatic cancer detection
$440,097Rosaura P.c. Valle · Milagen, Inc. · R44 · FY2009 · CA
Surrogate imaging biomarkers for tracking anti-stromal therapy
$440,024Marvin M Doyley · University Of Rochester · R56 · FY2017 · EB
Multiplexed Serum Biomarkers for Pancreatic Cancer
$439,968Anna E Lokshin · University Of Pittsburgh At Pittsburgh · U01 · FY2009 · CA
Exosomes as Endocrine Signaling Molecules in Cancer Cachexia
$439,793Daniel L Marks · Oregon Health & Science University · R01 · FY2021 · CA
Exosomes as Endocrine Signaling Molecules in Cancer Cachexia
$439,793Daniel L Marks · Oregon Health & Science University · R01 · FY2020 · CA